论文部分内容阅读
目的:研究美托洛尔在肺病合并心衰患者临床治疗中的疗效观察。方法:选取某院2014年1月~2015年1月收治的40例肺病合并心衰患者患者作为研究对象,分为观察组和对照组,对照组患者采用比索洛尔治疗,观察组患者采用美托洛尔治疗。结果:两组患者治疗前心功能比较差异无统计学意义(P>0.05),两组患者治疗后对照组心功能组间比较差异具有统计学意义(P<0.05);两组患者治疗显效和有效疗效组间比较具有统计学意义(P<0.05),组患者治疗无效和总有效率比较差异无统计学意义(P>0.05)。结论:采用美托洛尔对肺病合并心衰患者进行临床治疗,能够有效改善患者心功能,疗效显著,具有临床应用及推广价值。
Objective: To study the effect of metoprolol in the clinical treatment of patients with pulmonary disease complicated with heart failure. Methods: A total of 40 patients with pulmonary heart disease complicated with heart failure admitted to our hospital from January 2014 to January 2015 were selected as the observation group and the control group. The patients in the control group were treated with bisoprolol. The patients in the observation group were treated with the United States Tollor treatment. Results: There was no significant difference in cardiac function between the two groups before treatment (P> 0.05). There was significant difference in cardiac function between the two groups after treatment (P <0.05) The effective curative effect was statistically significant (P <0.05). There was no significant difference between the two groups in curative effect and total effective rate (P> 0.05). Conclusion: The clinical treatment of patients with pulmonary heart disease complicated with metoprolol can effectively improve the cardiac function of patients with significant curative effect, which has clinical application and promotion value.